A reimagined EDC (eCRF), grounded in experience
The EDC/eCRF has been at the heart of Datacapt since its launch. After years of continuous use in global studies, it has been redesigned from the ground up to reflect user feedback and evolving regulatory demands.
This new experience reaffirms Datacapt’s commitment to continuous improvement rather than incremental patches, ensuring that sites, CROs, and sponsors benefit from a best-in-class eCRF trusted in thousands of studies.
After analyzing thousands of site workflows and data collection patterns, Datacapt has redesigned its EDC/eCRF to meet the needs of both simple and complex studies. The result is an interface that reduces friction, saves time, and strengthens data quality from the first patient in to database lock.
The upgraded eCRF delivers:
- New interface for every study type: from straightforward registries to complex multi-arm designs, the layout adapts to investigator needs with fewer clicks and clearer navigation.
- Better data collection: auto-saving ensures no entry is lost, while validation highlights and intelligent edit checks prevent errors before they spread.
- Improved monitoring actions: always-accessible queries, audit trail, SDV, review, lock, and signature tools help monitors work faster and more efficiently.
- Optimized readability: redesigned layouts with visual dividers and real-time progress indicators make forms easier to complete and review.
Built on experience, invested for the future
“One truth is clear: old EDC systems no longer serve clinical research. With our new eCRF, we’re raising the bar again, delivering an EDC that is intuitive, efficient, and redefines what sites and sponsors should expect from modern clinical technology.” said Florentin ORY, CEO at Datacapt.
Revamped randomization with RTSM capabilities
Datacapt’s new randomization engine brings flexibility and control to complex trial designs. The module now supports:
- Multiple randomization methods (block, stratified, dynamic).
- Integrated supply management, enabling seamless RTSM workflows for both drug and device studies.
- Real-time allocation and tracking across sites.
By combining randomization with RTSM, sponsors can now manage both subject allocation and investigational product supply directly within Datacapt, eliminating the need for separate systems.
Strengthening Datacapt’s mission
“Clinical research teams are under pressure to move faster while maintaining the highest standards of quality and compliance.” said Khalil Ben Yahia, Clinical Partnership Specialist at Datacapt.
With the 4.19 release, Datacapt is delivering tools that simplify operations from EDC/eCRF entry to randomization and supply, so that sponsors and CROs can focus on science and patients, not on managing fragmented systems.
Availability
The 4.19 release will be rolled out globally at the end of October. Existing Datacapt clients will automatically benefit from the new eCRF interface and randomization solution.
For more details, visit the Datacapt website.
.webp)
.webp)
